FMR CORP 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
FMR CORP | 9,220,827 3.600% |
-3,760,459 (-28.97%) |
Filing |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
FMR CORP | 12,981,286 5.037% |
-4,895,488 (-27.38%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
FMR CORP | 17,876,774 6.964% |
8,643,205 (+93.61%) |
Filing |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
FMR CORP | 9,233,569 3.631% |
-4,273,301 (-31.64%) |
Filing |
| 2021-02-08 10:35 am Sale |
2021-02-05 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
FMR CORP | 13,506,870 5.194% |
-10,776,092 (-44.38%) |
Filing |